Cargando…
Role of glucosamine in development of diabetic neuropathy independent of the aldose reductase pathway
Long-term metabolic aberrations contribute to the development of diabetic neuropathy but the precise mechanism or mechanisms remains elusive. We have previously shown that aldose reductase-deficient mice exhibit delayed onset and progression of neuropathy following induction of diabetes, suggesting...
Autores principales: | Mizukami, Hiroki, Osonoi, Sho, Takaku, Shizuka, Yamagishi, Shin-Ichiro, Ogasawara, Saori, Sango, Kazunori, Chung, Sookja, Yagihashi, Soroku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713992/ https://www.ncbi.nlm.nih.gov/pubmed/33305258 http://dx.doi.org/10.1093/braincomms/fcaa168 |
Ejemplares similares
-
Aldose Reductase and the Polyol Pathway in Schwann Cells: Old and New Problems
por: Niimi, Naoko, et al.
Publicado: (2021) -
RAGE activation in macrophages and development of experimental diabetic polyneuropathy
por: Osonoi, Sho, et al.
Publicado: (2022) -
Polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductase
por: Hashimoto, Yasuhiro, et al.
Publicado: (2011) -
Amelioration of Acute Kidney Injury in Lipopolysaccharide-Induced Systemic Inflammatory Response Syndrome by an Aldose Reductase Inhibitor, Fidarestat
por: Takahashi, Kazunori, et al.
Publicado: (2012) -
Impaired Axonal Regeneration in Diabetes. Perspective on the Underlying Mechanism from In Vivo and In Vitro Experimental Studies
por: Sango, Kazunori, et al.
Publicado: (2017)